BiomX Prepares for Financial Results Announcement
BiomX Inc. (NYSE American: PHGE) is set to share significant updates regarding its third quarter financial results and ongoing programs. The announcement is scheduled to be made before the market opens on a Wednesday in mid-November. This will be an important opportunity for stakeholders and potential investors to gain insights into the company's performance and future directions.
Details of the Upcoming Call
The conference call will take place at 8:30 a.m. ET. BiomX encourages participants to register at least five minutes prior to the call to ensure smooth connectivity. For those who prefer to listen without engaging in questions, a live audio webcast will also be available.
Conference Call and Webcast Information
Here are the essential details for joining the conference call and the webcast:
Date: Wednesday, November 12, 2025
Time: 8:30 AM Eastern Time
Registration for Conference Call: Participants can register by visiting BiomX’s event registration link available on their official communications.
Webcast: A live link to the audio webcast will be provided, allowing users to connect via their devices for an efficient listening experience.
Accessing Archives and Further Information
Should attendees miss the live session, recorded versions of the call and webcast will be made available in the Investors section of BiomX's official website. This will allow individuals to catch up on any missed details regarding financial results and corporate strategies.
About BiomX and Its Innovations
BiomX Inc. is recognized for its cutting-edge work in the development of phage therapy, which targets and eliminates problematic bacteria responsible for chronic infections. Their innovative approach uses personalized treatments tailored to specific bacterial targets, leveraging the company’s proprietary BOLT (“BacteriOphage Lead to Treatment”) platform.
This phase of development aims to address significant unmet medical needs, particularly in areas where traditional antibiotic therapies fall short. BiomX is dedicated to furthering its mission, which includes discovering and validating unique bacterial targets to optimize phage therapy applications.
The Commitment to Health and Wellness
BiomX’s therapeutic solutions could pave the way for improved health outcomes in patients facing chronic conditions. With ongoing advancements and partnerships, BiomX is steadfast in its pursuit of excellence in phage technology and effective treatments.
Frequently Asked Questions
When will BiomX announce its Q3 2025 financial results?
BiomX is set to report its Q3 2025 financial results on November 12, 2025.
How can I participate in the financial results call?
You can participate by registering for the conference call online at least five minutes prior to the event's start time.
What technology does BiomX specialize in?
BiomX specializes in phage therapy, which utilizes natural and engineered phages to target and destroy harmful bacteria.
Will the financial results call be recorded?
Yes, both the live call and the webcast will be archived and made available on BiomX's website for future access.
Who can I contact for more information about BiomX?
You can reach out to Ben Cohen, Head of Corporate Communications, at benc@biomx.com for any inquiries regarding the company.